Skip to main content
. 2010 Jun 25;299(3):H605–H612. doi: 10.1152/ajpheart.01096.2009

Table 1.

Basic plasma parameters

Control Mice ApoE KO Mice ApoE KO with anti-LOX-1 Treatment ApoE KO Mice with Adiponectin Treatment
Body weight, g 28.9 ± 2.4 27.7 ± 2.6 34.1 ± 3.2 30.9 ± 4.0
Abdominal girth, cm 8.8 ± 0.2 8.5 ± 0.1 9.2 ± 0.4 9.1 ± 0.6
Total cholesterol, mg/dl 297.3 ± 128.7 646.1 ± 49.1* 486.8 ± 33.4* 514.8 ± 100.1
LDL, mg/dl 9.3 ± 9.3 438.6 ± 170.0* 539.1 ± 14.6* 542.1 ± 4.7*
HDL, mg/dl 132.6 ± 39.9 35.5 ± 32.4* 35.1 ± 30.0* 46.4 ± 28.2*
Resistin, ng/ml 7.9 ± 2.5 7.0 ± 1.7 7.7 ± 1.6 8.8 ± 2.7
Glucose, mg/dl 174.9 ± 24.5 173.0 ± 46.4 182.2 ± 53.6 178.1 ± 62.4
Adiponectin, μg/ml 4.4 ± 0.8 2.4 ± 0.9* 4.6 ± 0.9 3.9 ± 0.7
LOX-1, ng/ml 34.9 ± 15.8 96.7 ± 23.3* 52.9 ± 28.6* 57.1 ± 39.2*

Data are means ± SD; n = 4–6 animals/group. ApoE, apolipoprotein E; KO, knockout; LOX-1: Lectin-like oxidized LDL receptor-1.

*

P < 0.05 vs. control mice;

P < 0.05 vs. ApoE KO mice.